Skip to main content
Breaking
City Council Approves New Downtown Development ProjectSevere Thunderstorm Warning Issued for Dallas-Fort Worth AreaCity Council Approves New Downtown Development ProjectSevere Thunderstorm Warning Issued for Dallas-Fort Worth Area

Healthcare Briefs: Forte Biosciences Acquired In $2.2 Billion Deal By Amsterdam-based Agenx

Layten Praytor 4h agoDM
Healthcare Briefs: Forte Biosciences Acquired In $2.2 Billion Deal By Amsterdam-based Agenx
D Magazine

Dallas-based Forte Biosciences has been acquired by Amsterdam-based Agenx, a global immunology company, for $2.2 billion. The move adds Forte’s lead investigational therapy FB102 to Agenx’s immunology pipeline. FB102 is a first-in-class anti-CD122 antibody being developed to treat autoimmune diseases, including vitiligo and celiac disease, with additional potential applications in other immune-mediated conditions. The acquisition is … Continued The post Healthcare Briefs: Forte Biosciences Acquired In $2.2 Billion Deal By Amsterdam-based Agenx appeared first on D Magazine.

This article was originally published by D Magazine. Read the full story at the source below.

Read the Full Story

This story was originally published by D Magazine.

Read at D Magazine